Haemonetics Corporation · NYSE:HAE
T. Rowe Price Investment Management, Inc.'s stake in Haemonetics Corporation fell to 4.40% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 14, 2025
T. Rowe Price Investment Management, Inc.'s stake in Haemonetics Corporation fell to 4.40%, 2,195,569 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).
- Stake
- 4.40%
- Shares
- 2,195,569
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 4.40% | 2,195,569 |
Source
Related
- Haemonetics Corporation
- T. Rowe Price Investment Management, Inc.
- Haemonetics Corporation shareholders
- Schedule 13G/A · AQR Capital Management LLC · Aug 12, 2026
- Form 4 · Abernathy Robert E · Jul 28, 2026
- Form 4 · Madaus Martin D · Jul 28, 2026
- Form 4 · Zane Ellen M · Jul 28, 2026
- Form 4 · Pomeroy Claire · Jul 28, 2026